Klow80

Klow80 is a research-grade injectable peptide blend that combines BPC-157, TB500, GHK-Cu, and KPV. This formulation is designed for advanced experimental studies focusing on multi-system repair, inflammation resolution, and regenerative healing across various tissue models, including dermal and gastrointestinal systems. The synergistic effects of these peptides target angiogenic, anti-fibrotic, antioxidant, and immunomodulatory pathways, providing a comprehensive approach to recovery optimization in preclinical trauma and chronic condition simulations.

Core Components

• BPC-157: Known for its ability to accelerate tendon, ligament, and gut repair, BPC-157 promotes vascular endothelial growth factor (VEGF) upregulation and initiates anti-inflammatory cascades, demonstrating efficacy in ulcer healing and enhancing joint stability.
• TB500 (Thymosin Beta-4): This peptide enhances actin dynamics, facilitating cell migration and muscle rebuilding. It has been shown to reduce fibrosis and improve flexibility during injury recovery studies.
• GHK-Cu: GHK-Cu stimulates collagen and elastin synthesis while exhibiting copper-mediated antioxidant activity. Its applications include supporting skin rejuvenation, wound closure, and modulating hair growth.
• KPV: This peptide targets alpha-melanocyte-stimulating hormone (alpha-MSH) pathways, providing potent anti-inflammatory effects. It aids in maintaining gut barrier integrity, reducing cytokine storms, and accelerating mucosal healing in models of inflammatory bowel disease (IBD).

For research and laboratory use only. Not for human consumption.